Previous 10 | Next 10 |
Some in the investment community are spooked by the upcoming loss of Humira exclusivity. Revenue will likely fall in 2023, but the acquisition of Allergan, as well as the growth of revenue from Rinvoq, Skyrizi and Imbruvica should fill the gap. Management guides for high single-di...
I reveal two areas that I have invested half of my retirement funds into. I expect my hard-earned money to work as hard as I do, earning me more money. The main focus remains on high yield and recurrent income so I can enjoy my retirement. However, my new investment strategy t...
For income investors, closed-end funds remain an attractive investment class that covers a variety of asset classes and promise high distributions and reasonable total returns. The market downturn last year exposed the risk of high volatility and deep drawdowns with investing in close...
Tekla World Healthcare Fund (the “Fund”) (NYSE: THW) is pleased to announce the completion of its one for three non-transferable rights offering (the “Offering”) which expired Tuesday, April 6, 2021 (the “Expiration Date”). Pursuant to the Offer...
Tekla World Healthcare Fund (the “Fund”) (NYSE: THW) is pleased to announce the completion of its one for three non-transferable rights offering (the “Offering”) which expired Tuesday, April 6, 2021 (the “Expiration Date”). Pursuant to the Offer...
Despite the big rally in the general markets, the healthcare sector has barely participated despite having strong tailwinds. Today, the healthcare sector is a "deep value" sector that each investor should have a good allocation. Billionaire investor Warren Buffett recently placed ...
Goals and Objectives: Build an income portfolio with high yields and sustainable capital. THW is a category-leading fund that has seen an uncharacteristic premium valuation vanish. With its current near-par to small discount valuation, it offers a 9.5% yield with capital stability...
We still favor above-benchmark strategic allocations to China exposures, and see the recent weakness in Chinese markets offering an attractive entry point. The Federal Reserve made clear its commitment to be well "behind the curve" on inflation and wait to see it to materialize. I...
13 out of 23 CEF sectors positive on price and 13 out of 23 sectors positive on NAV last week. MLPs lead while commodities lag. BSTZ/BMEZ boosts distributions by +48.7% and +45.0% respectively. For further details see: Weekly Closed-End Fund Roundup: March 7, 2021
2 out of 23 CEF sectors positive on price and 2 out of 23 sectors positive on NAV last week. MLPs lead, while Asia equity lags. Some Nuveen funds increase distributions due to adoption of a level distribution policy. For further details see: Weekly Closed-End Fund Roundu...
News, Short Squeeze, Breakout and More Instantly...
Tekla World Healthcare Fund Shares of Beneficial Interest Company Name:
THW Stock Symbol:
NYSE Market:
There’s nothing we closed-end fund investors love more than finding a smartly run fund in an unfairly beaten-down sector. This hands us a nice discount (of course!), plus a much bigger dividend, because yields and prices move in opposite directions. In fact, with CEFs, we...
Most investors are ignoring a clear shot at 7%+ dividends double-digit price gains—year in and year out—in a sector everyone should be talking about, but isn’t. That would be healthcare, which is riding a rocket of rising spending: according to the latest number...
Tekla World Healthcare Fund (the “Fund”) (NYSE: THW) is pleased to announce the completion of its one for three non-transferable rights offering (the “Offering”) which expired Tuesday, April 6, 2021 (the “Expiration Date”). Pursuant to the Offer...